Determining the reliability of liver biopsies in NASH clinical studies
Nat Rev Gastroenterol Hepatol
.
2020 Nov;17(11):653-654.
doi: 10.1038/s41575-020-00363-8.
Authors
Thomas Longerich
1
,
Peter Schirmacher
2
Affiliations
1
Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
2
Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. Peter.schirmacher@med.uni-heidelberg.de.
PMID:
32887953
DOI:
10.1038/s41575-020-00363-8
No abstract available
Publication types
Comment
MeSH terms
Biopsy
Humans
Liver
Non-alcoholic Fatty Liver Disease* / diagnosis
Randomized Controlled Trials as Topic
Reproducibility of Results